Your browser doesn't support javascript.
loading
Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].
König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M.
Affiliation
  • König D; Department of Medical Oncology, University Hospital of Basel, Basel. Electronic address: david.koenig@usb.ch.
  • Schär S; Swiss Group for Clinical Cancer Research (SAKK), Bern.
  • Vuong D; Department of Radiation Oncology, University Hospital of Zurich, Zurich.
  • Guckenberger M; Department of Radiation Oncology, University Hospital of Zurich, Zurich.
  • Furrer K; Department of Thoracic Surgery, University Hospital of Zurich, Zurich.
  • Opitz I; Department of Thoracic Surgery, University Hospital of Zurich, Zurich.
  • Weder W; Clinics for Thoracic Surgery, Bethanien, Zurich.
  • Rothschild SI; Department of Medical Oncology, University Hospital of Basel, Basel.
  • Ochsenbein A; Department of Medical Oncology, University Hospital of Bern (Inselspital), Bern.
  • Zippelius A; Department of Medical Oncology, University Hospital of Basel, Basel.
  • Addeo A; Department of Oncology, University Hospital of Geneva, Geneva.
  • Mark M; Department of Oncology, Cantonal Hospital of Graubünden, Chur.
  • Eboulet EI; Swiss Group for Clinical Cancer Research (SAKK), Bern.
  • Hayoz S; Swiss Group for Clinical Cancer Research (SAKK), Bern.
  • Thierstein S; Swiss Group for Clinical Cancer Research (SAKK), Bern.
  • Betticher DC; Clinics of Medical Oncology, Cantonal Hospital of Fribourg (HFR), Fribourg.
  • Ris HB; Clinics for Thoracic Surgery, Hôpital du Valais, Sion, Switzerland.
  • Stupp R; Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Curioni-Fontecedro A; Department of Medical Oncology, University Hospital of Zurich, Zurich.
  • Peters S; Department of Medical Oncology, University Hospital of Lausanne (CHUV), Lausanne.
  • Pless M; Department of Medical Oncology, Cantonal Hospital of Winterthur, Winterthur.
  • Früh M; Department of Medical Oncology, University Hospital of Bern (Inselspital), Bern; Department of Medical Oncology/Hematology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
ESMO Open ; 7(3): 100494, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35468561
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2022 Type: Article